-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $70

Benzinga·05/06/2026 17:52:25
Listen to the news
HC Wainwright & Co. analyst Emily Bodnar maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target from $60 to $70.